Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Kappa-opioid receptor-selective antagonism by zyklophin.... | Download Scientific Diagram
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Signaling pathways in brain tumors and therapeutic interventions | Signal Transduction and Targeted Therapy
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Institutionen för klinisk neurovetenskap | Karolinska Institutet
Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance - ScienceDirect
Brain Sciences | Free Full-Text | Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Myelin in the Central Nervous System: Structure, Function, and Pathology | Physiological Reviews
Primary CNS lymphoma. Axial FLAIR (A), contrast-enhanced T1-weighted... | Download Scientific Diagram
Institutionen för klinisk neurovetenskap | Karolinska Institutet
Frontiers | Infection in the Developing Brain: The Role of Unique Systemic Immune Vulnerabilities
Primary CNS DLBCL. Lymphoma cells are round to oval and contain... | Download Scientific Diagram
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Pharmaceutics | Free Full-Text | Transport Mechanisms at the Blood–Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs
Specification of CNS macrophage subsets occurs postnatally in defined niches | Nature
Cureus | A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient | Article
Frontiers | GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
Minority Business Highlight: C-N-S Kitchen & Stuff - Indiana Minority Business Magazine
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Frontiers | Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | Uncovering incontinentia pigmenti: From DNA sequence to pathophysiology
